PREXXARTAN Drug Patent Profile
✉ Email this page to a colleague
When do Prexxartan patents expire, and when can generic versions of Prexxartan launch?
Prexxartan is a drug marketed by Carmel Biosciences and is included in one NDA.
The generic ingredient in PREXXARTAN is valsartan. There are forty drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the valsartan profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prexxartan
A generic version of PREXXARTAN was approved as valsartan by OHM LABS INC on June 26th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PREXXARTAN?
- What are the global sales for PREXXARTAN?
- What is Average Wholesale Price for PREXXARTAN?
Summary for PREXXARTAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 153 |
| Patent Applications: | 4,551 |
| What excipients (inactive ingredients) are in PREXXARTAN? | PREXXARTAN excipients list |
| DailyMed Link: | PREXXARTAN at DailyMed |
US Patents and Regulatory Information for PREXXARTAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carmel Biosciences | PREXXARTAN | valsartan | SOLUTION;ORAL | 209139-001 | Dec 19, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Carmel Biosciences | PREXXARTAN | valsartan | SOLUTION;ORAL | 209139-002 | Dec 19, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
